N/A
N=51
Skin Camouflage for Women Prisoners With Self-Harm Scarring
Self Injurious Behaviour
Bottom Line
View on ClinicalTrials.gov: NCT02638974 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Warwick-Edinburgh Mental Well-being Scale — 40.1739; 30.8182 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Medical Skin Camouflage (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Manchester
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Warwick-Edinburgh Mental Well-being Scale |
40.1739; 30.8182 | — |
| SECONDARY Becks Scale for Suicidal Ideation |
5.0435; 4.9412 | — |
| SECONDARY Becks Depression Inventory |
25.6957; 35.1364 | — |
| SECONDARY Becks Hopelessness Scale |
7.3636; 12.0000 | — |
| SECONDARY Rosenberg Self-Esteem Scale |
14.8696; 12.1818 | — |
| SECONDARY Adapted-DQLI |
6.7391; 11.9091 | — |
Summary
Women prisoners are more likely to commit suicide or self-harm than women in the community or male prisoners.
Healthcare services have improved how they manage self-harm in the community and prisons. However, there has been little focus on the recovery of people with self-harm scars. Medical skin camouflage (MSC) is a British National Formulary-listed topical cream designed to cover skin conditions. Research on MSC has focused on its use with non-self-harm marks e.g. burns. The evidence from this research suggests that the cream helps women feel better and do more activities. There is little/no evidence about the effects of the preparation for women who self-harm and for prisoners.
This research was funded by the National Institute for Health Research Research for Patient Benefit Programme. In the research the investigators will examine whether it is possible and practical to use MSC in prison. The investigators will ask women prisoners and staff what they think about the cream. The research has four parts. In the first part the investigators will run focus groups with women prisoners and prison staff to find out the best way to deliver the MSC intervention and how to measure its effects. In the second part the investigators will design a programme for delivering the MSC. The investigators will then train 6-10 long-term prisoners to become skin camouflage practitioners. The final part will involve a small randomised controlled trial with 40 women prisoners; 20 will be allocated to the intervention group and will use the MSC for 6 weeks. The investigators will measure their mood, thoughts of self-harm and wellbeing before and after they use MSC. The investigators will compare these results with 20 women who have not used MSC (waitlist control group). All women taking part will be placed at random into the control or the treatment group. The control group will receive the MSC after the research has ended.
Potential benefits of this study may be an increase in self-esteem and quality of life for the women prisoners. As women recover they may be less likely to self-harm.
Eligibility Criteria
Inclusion Criteria
- Remand and sentenced women prisoners screened for date of release with at least 6 weeks left on their sentence
- Self-harm scarring, with closed wounds (to allow the MSC to be applied).
- Able to give written, informed consent.
Exclusion Criteria
- Women prisoners with open wounds
- Less than 6 weeks on anticipated release date
- Women with skin conditions and allergies
- Women prisoners who lack the capacity to consent to the research.
Data sourced from ClinicalTrials.gov (NCT02638974). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.